+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Bags Market by Product Type, End User, Material, Sterilization Method, Technology - Global Forecast to 2030- Product Image
Blood Bags Market by Product Type, End User, Material, Sterilization Method, Technology - Global Forecast to 2030- Product Image
Sale

Blood Bags Market by Product Type, End User, Material, Sterilization Method, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082584
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Bags Market grew from USD 561.67 million in 2024 to USD 602.09 million in 2025. It is expected to continue growing at a CAGR of 6.86%, reaching USD 836.69 million by 2030.

Setting the Stage for the Blood Bags Market

Blood collection and storage remain at the heart of modern healthcare delivery, underpinning life-saving transfusions, advanced diagnostics, and critical research. As hospitals, clinics, and laboratories around the world strive to meet growing demand and stringent safety standards, the blood bags market has evolved into a dynamic arena defined by innovation, regulatory rigor, and shifting supply chain considerations.

This executive summary distills the most pivotal findings from in-depth industry analysis, presenting an integrated view of market drivers, emerging trends, and strategic imperatives. By examining transformative forces-from novel materials and sterilization methods to tariff developments and end-user requirements-this document equips decision-makers with the clarity needed to navigate complexity and capitalize on new opportunities.

Through a rigorous exploration of segmentation patterns, regional dynamics, and competitive strategies, readers will gain insight into the factors shaping demand and influencing pricing structures. Whether you oversee procurement, manufacturing, or clinical operations, this summary offers a concise yet comprehensive foundation for informed planning and decisive action.

Emerging Forces Redefining Market Dynamics

Healthcare delivery is undergoing a paradigm shift driven by technological breakthroughs, heightened safety expectations, and an intensified focus on patient outcomes. In the blood bags market, advanced materials such as polyolefin and EVA have emerged as viable alternatives to traditional PVC formulations, offering enhanced biocompatibility and reduced chemical leachables. Concurrently, novel sterilization techniques-particularly electron beam and gamma irradiation-are enabling manufacturers to meet stricter microbial thresholds while accelerating production cycles.

Digital transformation is equally reshaping operations across blood banks and hospital networks. From automated inventory management to real-time tracking of bag integrity, connected systems enhance transparency and minimize the risk of contamination or stockouts. At the same time, the integration of pathogen reduction technologies, including photochemical treatments and ultraviolet radiation, is elevating safety protocols and fostering confidence among clinicians and patients alike.

Regulatory frameworks are adapting in parallel, with agencies worldwide updating guidelines to reflect these innovations. As sustainability and environmental impact gain prominence, manufacturers are exploring DEHP-free solutions and streamlined device designs that reduce material waste. Together, these forces are redefining competitive dynamics, creating a market landscape where agility, compliance, and technological leadership are paramount.

Evaluating the 2025 Tariffs’ Ripple Effects on Supply Chains

In 2025, newly implemented tariffs on polymers, medical device components, and finished blood bags have introduced significant cost pressures for manufacturers reliant on cross-border supply chains. Raw material surcharges imposed at key ports have driven up production expenses, compelling producers to reassess sourcing strategies and pricing models. The cumulative effect has been most pronounced for companies importing PVC resin and specialized filter media from overseas suppliers.

Despite these headwinds, some manufacturers are pivoting to domestic production facilities or forging partnerships with regional resin producers to mitigate tariff impact. Nearshoring initiatives have accelerated investments in local polymer compounding and bag assembly lines, thereby preserving margin integrity and reducing lead times. Meanwhile, distributors are renegotiating contracts with end users to reflect the new cost base, often embedding clause adjustments for import duties.

End users, particularly diagnostic laboratories and research institutes with fixed reimbursement rates, are feeling the pinch of higher unit costs. As a result, hospitals and clinics are exploring longer product lifecycles and bulk procurement agreements to achieve economies of scale. Moving forward, the market is expected to see a gradual normalization of pricing as alternate supply networks mature, but near-term volatility remains a critical consideration for stakeholders across the value chain.

Uncovering Segmentation Patterns That Shape Market Demand

Market patterns emerge clearly when viewed through the lens of product variety, revealing that high-capacity bags-such as double and quadruple blood bags-remain indispensable for large-volume transfusions, while pediatric and single bags fulfill niche requirements in neonatal care and outpatient settings. Meanwhile, the growing adoption of satellite bag assemblies, particularly configurations with two or three detachable chambers, underscores the demand for modular collection systems that streamline component separation.

Examining end-use segments highlights the central role of blood banks as the primary procurement channel, supported by diagnostic laboratories that require specialized bags for plasma and cellular analysis. Hospitals and clinics drive continuous demand for conventional single and triple bags, whereas research institutes leverage advanced formats for experimental protocols, frequently prioritizing pathogen reduction compatibility.

Material selection further delineates market opportunities: non-PVC alternatives, led by EVA and polyolefin, are gaining traction in applications demanding minimal plasticizer exposure, while PVC variations continue to dominate cost-sensitive environments, with both DEHP-containing and DEHP-free options tailored to regulatory and safety considerations. Sterilization preferences reveal a shift toward electron beam and gamma irradiation methods for their speed and reliability, even as traditional steam sterilization maintains relevance in facilities with established infrastructure.

Technological segmentation underscores the ascent of leukoreduction filters-integrated via in-line or pre-storage configurations-to reduce immunogenic reactions, alongside pathogen reduction systems that employ photochemical or ultraviolet radiation treatments. These innovations collectively drive portfolio diversification, enabling suppliers to address evolving clinical protocols and regulatory benchmarks.

Regional Dynamics Driving Growth and Innovation

Across the Americas, established blood collection networks and favorable reimbursement frameworks support consistent demand for high-specification blood bags. Advanced manufacturing hubs in North America bolster domestic supply, while Latin American markets exhibit growing interest in DEHP-free and non-PVC solutions, driven by public health initiatives and bilateral trade agreements.

In Europe, Middle East, and Africa, diverse regulatory regimes create a mosaic of requirements that manufacturers must navigate carefully. Western European countries, with stringent safety mandates, lead adoption of pathogen reduction technologies, whereas emerging economies in Eastern Europe, the Gulf region, and Africa emphasize cost containment and supply reliability. Cross-border harmonization efforts by regional bodies are gradually simplifying compliance pathways, encouraging investment in local assembly and validation facilities.

The Asia-Pacific region represents the fastest-growing market, propelled by expanding blood donation campaigns, government subsidies for healthcare infrastructure, and increasing awareness of transfusion safety. Local producers are intensifying R&D to develop competitively priced non-PVC formulations, while multinational suppliers leverage joint ventures to meet surging demand in China, India, and Southeast Asia. Price sensitivity remains a critical driver, spurring manufacturers to optimize production efficiencies and streamline supply chains.

Profiling Industry Leaders and Their Strategic Moves

Leading manufacturers differentiate through robust portfolios and strategic initiatives. Established global players are investing heavily in next-generation materials research, forging collaborations with polymer specialists to enhance bag biocompatibility and extend storage lifespans. Concurrently, mid-sized firms are carving out niches by specializing in customization, offering tailored solutions for research institutes and specialized clinical programs.

Several key companies have pursued mergers and acquisitions to consolidate market share and achieve scale efficiencies. By integrating filter technology providers and sterilization service experts, these organizations are fortifying their end-to-end capabilities, from resin compounding to final packaging. Strategic alliances with logistics firms are further enhancing cold-chain reliability, ensuring bag integrity across long-haul shipments.

Innovative start-ups, leveraging digital labeling and RFID tagging, are gaining traction among tech-focused healthcare networks. Their ability to deliver real-time inventory monitoring aligns with the broader move toward digitized supply chains, prompting incumbents to accelerate their own technology roadmaps. As competitive intensity rises, success will hinge on balancing cost leadership with continuous product innovation and regulatory compliance.

Strategies for Leaders to Capitalize on Market Opportunities

Producers should prioritize diversification of raw material sources, securing contracts with multiple resin suppliers and evaluating captive compounding facilities to insulate against tariff fluctuations. Embracing non-PVC alternatives not only addresses shifting regulatory preferences but also positions portfolios for future sustainability mandates.

Investments in modular manufacturing lines can accelerate response times to emerging clinical needs, enabling rapid reconfiguration for different bag types, including satellite assemblies and pediatric formats. Additionally, fostering partnerships with sterilization service providers enhances scalability and maintains quality across varying throughput demands.

To capitalize on regional growth trajectories, companies must tailor market entry strategies to local regulations and reimbursement environments. Joint ventures or licensed manufacturing arrangements in high-growth markets can circumvent import duties and foster closer collaboration with healthcare systems. Concurrently, digital supply chain solutions-including RFID tracking and predictive analytics-will optimize inventory turnover and reduce waste.

Finally, cultivating alliances with research institutions to co-develop pathogen reduction and leukoreduction technologies can accelerate regulatory approvals and create first-mover advantages. By aligning R&D initiatives with clinical trial needs, industry leaders can ensure that new products address real-world challenges and deliver measurable improvements in patient safety.

Rigorous Framework Underpinning Market Analysis

This analysis is grounded in a two-tiered research approach combining primary interviews and secondary data aggregation. Detailed conversations with clinical experts, procurement managers, and supply chain executives provided qualitative insights into evolving requirements, technology adoption, and procurement practices. These firsthand perspectives were triangulated with manufacturer disclosures, regulatory filings, and peer-reviewed studies to validate emerging trends.

Secondary sources included industry journals, trade association reports, and government publications, offering comprehensive coverage of material innovations, sterilization approvals, and policy developments. Data from import-export databases illuminated cross-border trade flows and tariff impacts, while patent filings and clinical trial registries informed assessments of technological advancement.

Quantitative metrics were subjected to cross-validation, ensuring consistency between shipment volumes, production capacities, and end-user consumption patterns. Expert panels reviewed interim findings to refine segmentation frameworks and regional classifications. The result is a robust analytical foundation that combines empirical evidence with strategic foresight, enabling stakeholders to navigate market complexities with confidence.

Synthesis of Findings and Forward-Looking Perspectives

The evolving blood bags landscape is characterized by converging priorities: enhanced safety, material innovation, and supply chain resilience. Technological breakthroughs in filtration and pathogen reduction are reshaping clinical standards, while regional dynamics and tariff policies impose new constraints and opportunities.

Segmentation and competitive profiling reveal a market in transition, where agile manufacturers and strategic partnerships will define success. As demand patterns shift toward specialized formats and emerging regions gain prominence, the ability to align production capabilities with regulatory requirements and cost pressures will determine competitive positioning.

Ultimately, stakeholders who integrate data-driven insights with proactive innovation strategies will be best equipped to navigate this dynamic environment. By leveraging the findings presented here, industry leaders can make informed decisions that balance immediate challenges with long-term growth imperatives.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Double Blood Bags
    • Pediatric Blood Bags
    • Quadruple Blood Bags
    • Satellite Bags
      • Three Satellite
      • Two Satellite
    • Single Blood Bags
    • Triple Blood Bags
  • End User
    • Blood Banks
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Research Institutes
  • Material
    • Non PVC
      • EVA
      • Polyolefin
    • PVC
      • DEHP Containing
      • DEHP Free
  • Sterilization Method
    • Electron Beam
    • Ethylene Oxide
    • Gamma Irradiation
    • Steam Sterilization
  • Technology
    • Leukoreduction
      • In Line Filtration
      • Pre Storage Filtration
    • Pathogen Reduction System
      • Photochemical Treatment
      • Ultra Violet Radiation
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Terumo Corporation
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • MacoPharma S.A.S.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Kedrion S.p.A.
  • Sichuan Anke High-Tech Co., Ltd.
  • Vygon S.A.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Bags Market, by Product Type
8.1. Introduction
8.2. Double Blood Bags
8.3. Pediatric Blood Bags
8.4. Quadruple Blood Bags
8.5. Satellite Bags
8.5.1. Three Satellite
8.5.2. Two Satellite
8.6. Single Blood Bags
8.7. Triple Blood Bags
9. Blood Bags Market, by End User
9.1. Introduction
9.2. Blood Banks
9.3. Diagnostic Laboratories
9.4. Hospitals & Clinics
9.5. Research Institutes
10. Blood Bags Market, by Material
10.1. Introduction
10.2. Non PVC
10.2.1. EVA
10.2.2. Polyolefin
10.3. PVC
10.3.1. DEHP Containing
10.3.2. DEHP Free
11. Blood Bags Market, by Sterilization Method
11.1. Introduction
11.2. Electron Beam
11.3. Ethylene Oxide
11.4. Gamma Irradiation
11.5. Steam Sterilization
12. Blood Bags Market, by Technology
12.1. Introduction
12.2. Leukoreduction
12.2.1. In Line Filtration
12.2.2. Pre Storage Filtration
12.3. Pathogen Reduction System
12.3.1. Photochemical Treatment
12.3.2. Ultra Violet Radiation
13. Americas Blood Bags Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Blood Bags Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Blood Bags Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Terumo Corporation
16.3.2. Haemonetics Corporation
16.3.3. Fresenius Kabi AG
16.3.4. Grifols, S.A.
16.3.5. MacoPharma S.A.S.
16.3.6. Baxter International Inc.
16.3.7. B. Braun Melsungen AG
16.3.8. Kedrion S.p.A.
16.3.9. Sichuan Anke High-Tech Co., Ltd.
16.3.10. Vygon S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BLOOD BAGS MARKET MULTI-CURRENCY
FIGURE 2. BLOOD BAGS MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD BAGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD BAGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD BAGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD BAGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD BAGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BLOOD BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BLOOD BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BLOOD BAGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BLOOD BAGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BLOOD BAGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BLOOD BAGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD BAGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD BAGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD BAGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD BAGS MARKET SIZE, BY DOUBLE BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD BAGS MARKET SIZE, BY PEDIATRIC BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD BAGS MARKET SIZE, BY QUADRUPLE BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD BAGS MARKET SIZE, BY THREE SATELLITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD BAGS MARKET SIZE, BY TWO SATELLITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD BAGS MARKET SIZE, BY SINGLE BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD BAGS MARKET SIZE, BY TRIPLE BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD BAGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD BAGS MARKET SIZE, BY NON PVC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD BAGS MARKET SIZE, BY EVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD BAGS MARKET SIZE, BY DEHP CONTAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD BAGS MARKET SIZE, BY DEHP FREE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD BAGS MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD BAGS MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD BAGS MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD BAGS MARKET SIZE, BY IN LINE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD BAGS MARKET SIZE, BY PRE STORAGE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD BAGS MARKET SIZE, BY PHOTOCHEMICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD BAGS MARKET SIZE, BY ULTRA VIOLET RADIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BLOOD BAGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 68. CANADA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CANADA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 70. CANADA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 71. CANADA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 72. CANADA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 73. CANADA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CANADA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 75. CANADA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 127. GERMANY BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 129. GERMANY BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. GERMANY BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 132. GERMANY BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 133. GERMANY BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 134. GERMANY BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. GERMANY BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 137. FRANCE BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 139. FRANCE BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 142. FRANCE BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 143. FRANCE BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 144. FRANCE BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. FRANCE BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 157. ITALY BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 159. ITALY BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 161. ITALY BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 162. ITALY BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 163. ITALY BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 164. ITALY BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ITALY BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 166. ITALY BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 167. SPAIN BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 171. SPAIN BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 172. SPAIN BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 173. SPAIN BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 174. SPAIN BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. SPAIN BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 176. SPAIN BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 207. DENMARK BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. DENMARK BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 211. DENMARK BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 212. DENMARK BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 213. DENMARK BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 214. DENMARK BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. DENMARK BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 216. DENMARK BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 227. QATAR BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 229. QATAR BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 231. QATAR BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 232. QATAR BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 233. QATAR BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 234. QATAR BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. QATAR BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 236. QATAR BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 237. FINLAND BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 239. FINLAND BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. FINLAND BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 241. FINLAND BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 242. FINLAND BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 243. FINLAND BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 244. FINLAND BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. FINLAND BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 246. FINLAND BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 267. EGYPT BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. EGYPT BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 269. EGYPT BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EGYPT BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 271. EGYPT BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 272. EGYPT BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 273. EGYPT BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 274. EGYPT BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. EGYPT BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 276. EGYPT BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 277. TURKEY BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 279. TURKEY BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. TURKEY BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 281. TURKEY BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 282. TURKEY BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 283. TURKEY BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 284. TURKEY BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. TURKEY BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 286. TURKEY BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 297. NORWAY BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. NORWAY BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 299. NORWAY BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NORWAY BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 301. NORWAY BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 302. NORWAY BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 303. NORWAY BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 304. NORWAY BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. NORWAY BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 306. NORWAY BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 307. POLAND BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. POLAND BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 309. POLAND BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. POLAND BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 311. POLAND BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 312. POLAND BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 313. POLAND BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 314. POLAND BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. POLAND BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 316. POLAND BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 338. CHINA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. CHINA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 340. CHINA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. CHINA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 342. CHINA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 343. CHINA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 344. CHINA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 345. CHINA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 346. CHINA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 347. CHINA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 348. INDIA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 349. INDIA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 350. INDIA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. INDIA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 352. INDIA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 353. INDIA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 354. INDIA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 355. INDIA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 356. INDIA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 357. INDIA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 358. JAPAN BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 359. JAPAN BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 360. JAPAN BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 361. JAPAN BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 362. JAPAN BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 363. JAPAN BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 364. JAPAN BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 365. JAPAN BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 366. JAPAN BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 367. JAPAN BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 368. AUSTRALIA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 369. AUSTRALIA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 370. AUSTRALIA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 371. AUSTRALIA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 372. AUSTRALIA BLOOD BAGS MARKET SIZE, BY NON PVC, 2018-2030 (USD MILLION)
TABLE 373. AUSTRALIA BLOOD BAGS MARKET SIZE, BY PVC, 2018-2030 (USD MILLION)
TABLE 374. AUSTRALIA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 375. AUSTRALIA BLOOD BAGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 376. AUSTRALIA BLOOD BAGS MARKET SIZE, BY LEUKOREDUCTION, 2018-2030 (USD MILLION)
TABLE 377. AUSTRALIA BLOOD BAGS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, 2018-2030 (USD MILLION)
TABLE 378. SOUTH KOREA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 379. SOUTH KOREA BLOOD BAGS MARKET SIZE, BY SATELLITE BAGS, 2018-2030 (USD MILLION)
TABLE 380. SOUTH KOREA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 381. SOUTH KOREA BLOOD BAGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 382. SOUTH KOR

Companies Mentioned

The companies profiled in this Blood Bags market report include:
  • Terumo Corporation
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • MacoPharma S.A.S.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Kedrion S.p.A.
  • Sichuan Anke High-Tech Co., Ltd.
  • Vygon S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 602.09 Million
Forecasted Market Value ( USD ) by 2030 $ 836.69 Million
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Disposable Leukocyte Plastic Blood Bag Market by Product Type, End-User, Material Type, Application, Sales Channel - Global Forecast to 2030 - Product Image

Disposable Leukocyte Plastic Blood Bag Market by Product Type, End-User, Material Type, Application, Sales Channel - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Medical Fluid Bags Market by Product Type, Material, End User, Delivery Mode, Sterilization Method - Global Forecast to 2030 - Product Image

Medical Fluid Bags Market by Product Type, Material, End User, Delivery Mode, Sterilization Method - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Medical Specialty Bags Market Size, Share & Trends Analysis Report By Product (Ostomy Collection Bags, Urinary Collection Bags, Blood Bags, Bile Collection Bags, Sterile Packaging Bags), Region, And Segment Forecasts, 2024 - 2030 - Product Image

Medical Specialty Bags Market Size, Share & Trends Analysis Report By Product (Ostomy Collection Bags, Urinary Collection Bags, Blood Bags, Bile Collection Bags, Sterile Packaging Bags), Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Global Disposable Blood Bags - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Disposable Blood Bags - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 111 Pages
  • Global
From
Blood Bags - Global Strategic Business Report - Product Image

Blood Bags - Global Strategic Business Report

  • Report
  • 392 Pages
  • Global
From

About the Blood Bag Market

Blood bags are medical devices used to collect, store, and transport blood and blood components. They are typically made of plastic and are designed to be sterile and leak-proof. Blood bags are used in a variety of medical procedures, including blood transfusions, blood donations, and the collection of stem cells. They are also used in research and laboratory settings. Blood bags come in a variety of sizes and shapes, and are equipped with a variety of features, such as filters, valves, and connectors. They are also designed to be compatible with a range of medical equipment, such as centrifuges and pumps. The blood bag market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include B. Braun, Fresenius Kabi, Terumo, Macopharma, and Haemonetics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.